Are you Dr. Boyiadzis?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Meyran Ave
Suite 318
Pittsburgh, PA 15213Phone+1 412-586-9874Fax+1 412-647-4486
Summary
- Dr. Michael Boyiadzis, MD is an oncologist in Pittsburgh, Pennsylvania. He is an Assistant Professor at University of Pittsburgh School of Medicine.
Publications & Presentations
PubMed
- A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia.Kevin Quann, Konstantinos Lontos, Alison Sehgal, Anastasios Raptis, Annie Im
Haematologica. 2024-12-01 - 1 citationsPhase 2 study of epigenetic priming with decitabine followed by cytarabine for acute myeloid leukemia in older patients.Annie Im, Kevin Quann, Mounzer Agha, Anastasios Raptis, Robert L Redner
American Journal of Hematology. 2024-03-01 - 7 citationsA study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML.Sheng F Cai, Ying Huang, Jennie R Lance, Hsiaoyin Charlene Mao, Andrew J Dunbar
Blood Advances. 2024-01-23
Press Mentions
- DPP4+ Exosomes in AML Patients’ Plasma Suppress Proliferation of Hematopoietic Progenitor CellsNovember 2nd, 2020